[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-370008-105":59,"doc-detail-370008-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","hepatoid-adenocarcinoma-of-the-stomach-and-non-hepatoid-alphafetoprotein-producing-gastric-cancer-exhibit-a-high-degree-of-molecular-similarity","Hepatoid adenocarcinoma of the stomach and non-hepatoid alphafetoprotein-producing gastric cancer exhibit a high degree of molecular similarity","","There is currently no unified consensus on diagnosing and treating hepatoid adenocarcinoma of the stomach (HAS) and non-hepatoid AFP-producing gastric cancer (AFPGC). This study explores whether these two subtypes share molecular traits that could support more consistent diagnosis and precision treatment strategies. Tumor tissues, adjacent tissues, and peripheral blood were collected from 83 patients and analyzed using whole-exome or transcriptome sequencing approaches.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/hepatoid-adenocarcinoma-of-the-stomach-and-non-hepatoid-alphafetoprotein-producing-gastric-cancer-exhibit-a-high-degree-of-molecular-similarity/370008/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/hepatoid-adenocarcinoma-of-the-stomach-and-non-hepatoid-alphafetoprotein-producing-gastric-cancer-exhibit-a-high-degree-of-molecular-similarity/370008.png","ImageObject",300,407,{"name":92,"@type":93},"nayy☆","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-31","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the study’s main objective regarding HAS and non-hepatoid AFPGC?","Question",{"text":112,"@type":113},"To investigate the molecular similarities between hepatoid adenocarcinoma of the stomach (HAS) and non-hepatoid AFP-producing gastric cancer (AFPGC) to support diagnosis and precision treatment.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were patient samples analyzed in this research?",{"text":117,"@type":113},"Tumor tissues, adjacent tissues, and peripheral blood from 83 patients were collected and assessed using whole-exome sequencing or transcriptome sequencing, followed by correlation and clustering analyses.",{"name":119,"@type":110,"acceptedAnswer":120},"What key molecular similarity findings were reported?",{"text":121,"@type":113},"Both groups shared high-frequency mutated genes such as TP53, LRP1B, MUC16, CSMD3, and FAT4, showed similar copy number variations, and exhibited clustering trends in transcriptomic data distinct from conventional gastric adenocarcinoma.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},370008,1790197198,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},962090893153,"https://ap-avatar.wpscdn.com/davatar_9964176cb1d06d4a9deccf72a44ae3dc","Cellular Oncology (2026) 49:1  \n[https://doi.org/10.1007/s13402-025-01](https://doi.org/10.1007/s13402-025-01)145-7  \nRESEARCH  \nHepatoid adenocarcinoma of the stomach and non-hepatoid alphafetoprotein-producing gastric cancer exhibit a high degree of molecular similarity  \nLiqiao Chen1 · Xuesong Yang2 · Peiyu Zhu1 · Han Bao4 · Yan Wu3 · Ke Ji1 · Ji Zhang1 · Xiaojiang Wu1 · Kai Zhou1 · Jieli Xu1 · Jiatian Tang1 · Anqiang Wang1 · Zhaode Bu5  \nReceived: 30 July 2025 / Accepted: 30 October 2025 © The Author(s) 2025  \nAbstract  \nBackground There is currently no unified consensus on the diagnosis and treatment of hepatoid adenocarcinoma of the stomach (HAS) and non-hepatoid AFP-producing gastric cancer (AFPGC) . This study aims to explore the molecular similarities between the two, providing a basis for the diagnosis and precision treatment of these patients.  \nMethods We retrospectively collected tumor tissues, adjacent tissues, and peripheral blood samples from 83 patients for whole-exome sequencing or transcriptome sequencing. Spearman correlation analysis, unsupervised clustering analysis and so on were performed to assess the similarity between different sample groups, explore the molecular features of non-hepatoidAFPGC and HAS, and compare their correlations.  \nResults All the patient groups shared high-frequency mutated genes such as TP53, LRP1B, MUC16, CSMD3, and FAT4 . Copy number variation analysis revealed similarities in the copy number variations between the two patient groups. The majority of patients in both groups exhibited amplification of the CCNE1 or ERBB2 . PCA analysis based on transcriptomic data showed a clear clustering trend within the HAS and non-hepatoidAFPGC subgroups, which was distinct from conventional gastric adenocarcinoma. Moreover, unsupervised clustering analysis indicated that the samples within the different subgroups of the two groups had similar transcriptional expression patterns. Finally, we identified a potential therapeutic target, FAT4. Mutations in FAT4 further affect transcriptional expression and prognosis in gastric cancer patients, as well as influence immune infiltration and the response to immune checkpoint blockade therapy.  \nConclusion HAS and non-hepatoidAFPGC exhibit a high degree of similarity at both the genomic and transcriptomic levels. Clinical trial number Not applicable.  \nLiqiao Chen, Xuesong Yang and Peiyu Zhu contributed equally to this work.  \n􀀍 Anqiang Wang [drwang726@hsc.pku.edu.cn](drwang726@hsc.pku.edu.cn)  \n􀀍 Zhaode Bu [buzd@cjcrcn.org](buzd@cjcrcn.org)  \n1 Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Center of Gastrointestinal Cancer, Peking University Cancer Hospital and Institute, Beijing 100142, China  \n2 Department of Gastrointestinal Surgery, Peking University Shenzhen Hospital, Shenzhen 518036, China  \n3 Department of Pathology, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital & Institute, Beijing  \n100142, China  \n4 Peking University First Hospital, Beijing 100034, China  \n5 State Key Laboratory of Holistic Integrative Management of Gastrointestinal Cancers, Center of Gastrointestinal Cancer, Peking University Cancer Hospital and Institute, Beijing 100142, China  \n1 3  \nGraphical Abstract  \nKeywords Hepatoid adenocarcinoma of the stomach · Non-hepatoid AFP-producing gastric cancer · Whole-exome sequencing · Transcriptome sequencing  \n1 Introduction  \nOver the past several decades, the incidence and mortality rates of gastric cancer have decreased globally. However, it remains the fifth most common cancer and the third leading cause of cancer-related death worldwide [1, 2] . In high-incidence regions, particularly East Asian countries, the health and economic burden posed by gastric cancer remains significant. According to the latest data from the National Cancer Center of China, as of 2022, the incidence and mortality rates of gastric cancer in ","cbCaidrTNZkQbL2k","https://ap.wps.com/l/cbCaidrTNZkQbL2k","pdf",8274658,13,"English","# Introduction\n# Abstract\n## Background\n## Methods\n## Results\n## Conclusion\n# Keywords","[{\"question\":\"What is the study’s main objective regarding HAS and non-hepatoid AFPGC?\",\"answer\":\"To investigate the molecular similarities between hepatoid adenocarcinoma of the stomach (HAS) and non-hepatoid AFP-producing gastric cancer (AFPGC) to support diagnosis and precision treatment.\"},{\"question\":\"How were patient samples analyzed in this research?\",\"answer\":\"Tumor tissues, adjacent tissues, and peripheral blood from 83 patients were collected and assessed using whole-exome sequencing or transcriptome sequencing, followed by correlation and clustering analyses.\"},{\"question\":\"What key molecular similarity findings were reported?\",\"answer\":\"Both groups shared high-frequency mutated genes such as TP53, LRP1B, MUC16, CSMD3, and FAT4, showed similar copy number variations, and exhibited clustering trends in transcriptomic data distinct from conventional gastric adenocarcinoma.\"}]","Hepatoid adenocarcinoma of the stomach and non-hepatoid alphafetoprotein-producing gastric cancer exhibit a high degree of molecular similarity | PDF",1790186235,33,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f8bb6689903aa02a35a5d31f472d6576.webp",983,1305,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/af37934ef9411abc1f5696a4090fa246.webp",982,1304,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c131b0bc10392d3f2148ea6554322d49.webp",981,1303,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d7e104cbcfd7f21633f50e8c7a6a5d31.webp",980,1301]